Kiwifruit allergy across Europe

详细信息    查看全文

• 作者：T.M. Le ; ^{t.t.m.le-2@umcutrecht.nl" class="auth_mail" title="E-mail the corresponding author} ; A.C. Knulst
• 关键词：EuroPrevall ; Component-resolved diagnosis ; Diagnosis ; Food allergy ; Kiwi
• 刊名：Revue Française d'Allergologie
• 出版年：2015
• 出版时间：November 2015
• 年：2015
• 卷：55
• 期：7
• 页码：470-473
• 全文大小：422 K

文摘

Kiwifruit has a high nutritive and health value. Commercial plantings of kiwifruit started a few decades ago and in the last 30 years, it has become a widely consumed fruit. Nowadays, it is one of the most common causes of food allergy. Symptoms vary between mild symptoms in the oral cavity to severe anaphylactic reactions. To date, 13 kiwifruit allergens have been identified and are termed as Act d 1 through Act d 13. The use of kiwifruit components improves the diagnostic performance compared to skin prick-test and immunoCAP with kiwifruit extract. Kiwifruit allergen sensitization patterns differ across Europe with patients from Iceland, mainly sensitized to Act d 1 (actinidin), those from western/central and eastern Europe mainly sensitized to the birch pollen-related Act d 8, and patients from southern Europe mainly sensitized to Act d 9 (profilin) and Act d 10 (nsLTP). Act d 1 and having kiwifruit allergy in Iceland are independent risk factors for a severe kiwifruit allergy. Some kiwifruit cultivars (the common gold kiwifruit Hort16A and the more recently introduced green kiwifruit Summer 3373) may be less allergenic than the common green kiwifruit Hayward and may be a safe alternative for (part of) kiwifruit allergic patients.